The Canadian Press - ONLINE EDITION

J&J 2Q profit rises 13 per cent to $4.33B, beats forecast on sales growth for new medicines

  • Print

Johnson & Johnson on Tuesday reported a 13 per cent jump in second-quarter profit, fueled mainly by strong sales of several new medicines. The results topped analysts' expectations.

The maker of Band-Aids, medical devices and biologic drugs raised its 2014 profit forecast for the second time this year, again up by a nickel to a new range of $5.85 to $5.92 per share. J&J shares rose 28 cents to $105.38 in premarket trading.

J&J said earnings increased to $4.33 billion, or $1.51 per share, from $3.83 billion, or $1.33 per share, in the same quarter a year ago.

Earnings, adjusted for non-recurring costs, came to $1.66 per share. The average per-share estimate of analysts surveyed by Zacks Investment Research was $1.54.

The world's biggest maker of health care products said revenue rose 9.1 per cent to $19.5 billion from $17.88 billion in the same quarter a year earlier, and beat Wall Street forecasts. Analysts expected $18.85 billion, according to Zacks.

The New Brunswick, New Jersey-based company said prescription drug sales rose 21 per cent to $8.51 billion, as sales climbed for new drugs including Olysio for hepatitis C and Xarelto for preventing heart attacks and strokes. The strong performance of the segment recently has helped it regain the lead over J&J's device business and offset the lagging consumer segment, which is still recovering from dozens of product recalls since 2009.

Medical device sales edged up 0.7 per cent to $7.24 billion, while consumer product sales increased 2.4 per cent to $3.74 billion.

Johnson & Johnson shares have increased $13.79, or 15 per cent, to $105.38 since the beginning of the year, while the Standard & Poor's 500 index has increased 7 per cent. The stock has risen $14.98, or 17 per cent, in the last 12 months.

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes

    No

  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Bowman pledges to find efficiencies at City Hall

View more like this

Photo Store Gallery

  • A gosling stares near water at Omands Creek Park-See Bryksa 30 day goose challenge- Day 25– June 21, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)
  • A goose flys defensively to protect their young Wednesday near Kenaston Blvd and Waverley -See Bryksa 30 Day goose challenge- Day 16 - May 23, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)

View More Gallery Photos

Poll

Do you think e-cigarettes should be banned by the school division?

View Results

Ads by Google